VOKANAMET® (canagliflozin and immediate release metformin hydrochloride fixed dose combination) approved in the European Union for treatment of adults with type 2 diabetes
- EMEA Innovative Medicine
- VOKANAMET® (canagliflozin) Approved in the EU for Adult Type 2 Diabetes
VOKANAMET® (canagliflozin) Approved in the EU for Adult Type 2 Diabetes
- X (Twitter)
Copy link